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Few studies have investigated the relationship between physical activity (PA) of low inten-
sity and duration with quality of life (QoL) among individuals at risk or with cardiovascular
disease (CVD).
Objectives
To investigate whether PA of different intensity and duration moderates the relationship
between CVD and its risk factors (obesity, hypertension, diabetes, dyslipidaemia) and QoL
in adults.
Methods
Population-based cross-sectional studies using data from the EpiFloripa Cohort Study
(Southern Brazil; n = 1,220, 38.8±12.0 years, 48.2% males) and the North West Adelaide
Health Study (NWAHS, South Australia; n = 1,661, 43.7±11.1 years, 49.7% males). The
physical and psychological domains of QoL were assessed using the WHOQOL-Bref
(EpiFloripa) or the SF-36 (NWAHS) questionnaires. The diagnosis of CVD and its risk
factors were self-reported. PA was self-reported and quantified by its intensity [“walking”
or moderate/vigorous (MVPA)] and duration (none, 1–150, 150 min/week). Both
studies were analysed separately, and results were adjusted for sociodemographic
variables.
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Results
Participants at risk or with CVD from both studies showed a lower QoL than ‘healthy’ individ-
uals with a stronger relationship for the physical domain. PA duration showed a direct-trend
relationship with QoL, but the associations were stronger for MVPA in both studies. How-
ever, when stratified by health status, the magnitude of the association between “walking”
duration and a higher physical QoL was greater among those at risk or with CVD compared
to ‘healthy’ individuals. Conversely, among Australians with CVD, MVPA was associated
with a better physical QoL only when its duration was150 min/week. All associations were
stronger in the NWAHS than in the Brazilian study.
Conclusions
“Walking” was more prevalent than MVPA and was consistently associated with a better
physical QoL among those at risk or with CVD. These findings should be considered in the
design of public health interventions designed to increase PA and improve QoL.
Introduction
Worldwide, the burden of cardiovascular disease (CVD) and its risk factors have taken centre
stage in noncommunicable disease (NCD) policies [1, 2]. CVD accounts for 31% of global
deaths. While the majority of these deaths occur in low and middle-income countries, the pro-
portion of deaths due to CVD when compared to other causes is even greater among high-
income countries [1, 2]. According to the World Economic Forum, NCDs will cause a global
loss of US$ 47 trillion over the following two decades, with CVD being the most important
contributor [3]. Moreover, although the prevalence of some NCDs has recently declined in
many high- and some middle-income countries, CVD mortality has plateaued, especially
among the high-income countries [4].
CVD also has a profound impact on physical and mental health, self-esteem, and the daily
lives of affected individuals [5–7]. The Global Burden of Disease estimates that between 1990
and 2010 the disability-adjusted life-year (DALYs) of CVDs increased by 22.6%, becoming the
leading cause of DALYs worldwide [8, 9]. In this scenario, appropriate long-term management
of CVD is fundamental for reducing acute events, further complications, and health expendi-
ture, as well for improving life expectancy and quality of life (QoL) [10].
Among the non-pharmacological strategies for the prevention and management of patients
at risk of—or with—CVD, physical activity (PA) has been shown to be beneficial for improv-
ing physical health and physiological parameters, as well as reducing complications and mor-
tality [11–15]. The World Health Organization recommends that adults should perform at
least 150 minutes/week of moderate PA or 75 minutes/week of vigorous PA (MVPA) or an
equivalent combination of both as this is associated with a reduced risk of developing diverse
NCDs and premature mortality in the general population [16]. Nonetheless, some studies sug-
gest that these recommendations may be difficult to achieve among individuals with functional
limitations, such as those affected by CVD, and lower levels of PA may still be beneficial for
reducing the risk of coronary heart events and encouraging individuals to integrate PA as part
of their daily lifestyle [12, 17]. Furthermore, PA seems to improve other health outcomes
among patients with CVD, including different domains of QoL [13, 18].
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QoL is a subjective outcome that assesses individuals’ perceptions of the impact of diverse
conditions on their daily living, including their social and cultural context [19]. This patient-
centred outcome has become increasingly important in the study of CVD due to its close rela-
tionship with physical functioning, adherence to health management, hospitalisations, and
mortality [20]. PA has been consistently associated with a better QoL in the general adult pop-
ulation [21]. However, the impact of PA on QoL among individuals at risk or with CVD has
not been sufficiently evaluated in population-based studies. Furthermore, most research in
this field has been conducted in hospital/clinical settings from high-income countries, espe-
cially among those located in the Northern hemisphere [18, 22–24].
Therefore, investigating the association between PA of different intensity and duration and
the QoL among individuals at risk of, or with, CVD using population-based samples is crucial
to be able to give more accurate advice about the volume and intensity of PA that can improve
health in different socioeconomic contexts. In this sense, Brazil and Australia are two countries
in the Southern hemisphere with a similar profile in terms of CVD mortality (33% and 35% of
all deaths, respectively), risk factors (prevalence of diabetes mellitus being 8% in both coun-
tries, overweight being 54% and 66% respectively, and hypertension being 23% and 15%,
respectively) as well as lifestyle characteristics (prevalence of smoking being 17% and 16%
respectively, and insufficient PA being 84% in both countries) [25, 26]. There is also universal
access to a comprehensive range of health services in both countries, including community
and emergency health services [27–30]. Nonetheless, Brazil and Australia, as middle-income
and high-income countries, are very different according to other indicators such as life-expec-
tancy (73 in Brazil vs 82 years in Australia) and the human development index (0.754 in Brazil
vs 0.939 in Australia) [31].
Therefore, in this study we used data from two population-based cohort studies from
Southern Brazil and South Australia to explore and compare the association between CVD
and CVD risk factors on QoL, as well as assess whether PA of different intensity and duration
moderates that relationship.
Material and methods
Study design and setting
This is a cross-sectional study using data from the EpiFloripa Adult Cohort Study (Floriano´po-
lis, Southern Brazil) and the North West Adelaide Health Study (NWAHS, Adelaide, South
Australia). The Brazilian cohort study was conducted between 2009–2014 and included 1,720
participants aged 20–59 years at the baseline. The Australian cohort study was conducted
between 2000–2010 and involved 4,056 individuals aged 18–95 years at the baseline. Ethics
approval was obtained from the Human Research Ethics Committees at the Federal University
of Santa Catarina (Brazil) and The University of Adelaide (Australia). All participants signed
their respective consent forms.
Data collection/participants
A random sampling of the population was used to select participants in both studies and
details have been published elsewhere (S1 Fig) [32, 33]. In summary, the target population in
the baseline of the EpiFloripa study (2009–2010) included individuals living in the urban area
of Floriano´polis (97% of the inhabitants), a state capital in Southern Brazil. Firstly, ten census
sectors were systematically selected in each decile of household income (63/420 sectors), and
then 1,134/16,755 households in these sectors were systematically selected. Excluding individ-
uals with severe mental or physical disabilities, all adults aged 20–59 years living in these
households were eligible for the study. Considering a mean of 1.78 per dwelling, the sampling
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process allowed the identification of 2,016 adults. All participants evaluated in the baseline
(N = 1,720) were traced in 2012–2013 (second wave) and 71% were interviewed (S1 Fig). In
both waves, participants were home interviewed and data were collected using face-to-face
questionnaires with direct measurement of clinical and anthropometric variables.
All households in Northern and Western Adelaide connected to a landline telephone were
considered eligible in the baseline of the NWAHS (2000–2003; 97.9% of households in these
areas). The target population represented half of the 1.1 million inhabitants in the metropoli-
tan area of Adelaide and one-third of the population in South Australia. One adult aged 18+
years living in the randomly selected households was arbitrarily selected (excluding those
unable to communicate in English or with severe illness). Data were collected using a combi-
nation of phone interviews (Computer Assisted Telephone Interviews), self-administered
questionnaires posted to the address of the participants, and clinical assessments at two Cen-
tral Northern Adelaide Health Service health centres. A total of 4,056 individuals of the 8,213
eligible individuals completed the interviews and attended the clinics. The second and third
waves of the study were performed in 2006–2007 (n = 3,564) and 2008–2010 (n = 2,871)
respectively. Analyses of the NWAHS for this study were restricted to those interviewed in
2008–09 and aged <65 years (n = 1,661) to get a comparable sample with the Brazilian study
(aged 23–63 years in 2012).
Outcome: Quality of life
In the EpiFloripa study, QoL was measured in 2012–2013 (second wave) using the Portuguese
version of the World Health Organization Quality Instrument for Quality of Life Assessment
(WHOQOL-Bref). This 26-item instrument generates four 0-100-scale domains (physical, psy-
chological, environmental, and social relationships) [34].
For the NWAHS, the physical and mental component scores of QoL were assessed in 2008–
2010 (third wave) using the 36-Item Short Form Survey (SF-36) [35, 36]. The questionnaire
consists of 36 questions, which generate eight sub-domains (physical functioning, role-physi-
cal, bodily pain, general health, vitality, social functioning, role-emotional, and mental health).
These sub-domains were combined to generate the physical and mental component scores
using recommended algorithms [35].
WHOQOL-Bref and SF-36 were developed to measure different constructs (QoL or
Health-related QoL, respectively), include different domains, and are expressed in different
scales (WHOQOL-BrefMean = 70 points; SF-36Mean = 50 points) [19, 37]. Nonetheless, both
instruments have consistently identified the adverse relationship of CVD and their risk factors
on QoL, as well as the benefits of PA levels on that outcome. Therefore, to obtain comparable
results, only the physical and psychological domains of the WHOQOL-Bref were analysed.
Additionally, for this study, we will use the terms “physical” or “psychological” domains of
QoL independent of the instrument used to measure these outcomes in each study.
Clinical conditions: Cardiovascular disease and risk factors
In both studies, information collected in different waves were used to identify those individu-
als at risk of or with CVD (baseline in the EpiFloripa study and at baseline and third wave of
the NWAHS) (S1 Fig). Individuals at risk were defined as those with hypertension, dyslipidae-
mia, diabetes mellitus, obesity, and/or abdominal obesity, but not CVD [25, 26]. Obesity was
defined as a body mass index (BMI)30 kg/m2 based on measured weight and height (Epi-
Floripa, 2012–2013; NWAHS, 2008–2010). Abdominal obesity was defined as being in the
upper quartile of waist circumference separately for each sex (EpiFloripa = men >99.0 cm and
women >89.6 cm; NWAHS >108.3 cm and>99.1 cm, respectively). The recommended
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WHO cut-off points for waist circumference were not used because of the lack of consensus
for different ethnic groups; for example, overestimating the prevalence of abdominal obesity
among Latin-American women by more than 30% [38].
The other risk factors were identified based on self-reported medical diagnoses of these
conditions (“Has a medical doctor ever told that you have. . .?”) and combined with the use of
medication for these conditions. Similarly, participants were questioned about previous diag-
noses of CVD (i.e. myocardial infarction, angina, heart failure, atrial fibrillation/arrhythmia,
and/or stroke) using data from the baseline in the EpiFloripa study and third wave in the
NWAHS. Based on all this information, individuals were classified as: 1) negative for all these
conditions (None), 2) at risk of CVD (but without CVD), or 3) with CVD (with or without a
risk factor).
Moderator: Physical activity levels
PA was measured in the baseline of the EpiFloripa study using questions from the Surveillance
of Risk and Protective Factors for Non-Transmissible Chronic Diseases by Telephone Inter-
views (VIGITEL) [39]. In the NWAHS, PA was assessed in the third wave using items from
the Active Australia Questionnaire (AAQ) [40, 41]. Both instruments have shown good reli-
ability and validity when compared to gold standard methods in the assessment of PA levels
(moderate correlations, sensibility 50–70%, specificity of at least 80%). In both studies, PA was
self-reported and based on different questions regarding the weekly volume (number of days
and total time) and intensity (light, moderate, vigorous) of leisure and/or transportation activi-
ties performed regularly (over the past three months in Brazil and over the last week in Austra-
lia). For analytical purposes, “walking” for recreation, exercise, or transportation was analysed
separatedly, as it could include moderate but also low intensity PA (activities with a a meta-
bolic equivalent (1 MET = 1 kcal/kg/hour) < 3.0) [42]. “Moderate intensity” PA was defined
as exercise causing a moderate increase in heart rate or breathing (equivalent to 3.0–5.0 MET),
such as running, lawn bowls, golf, swimming, dancing, or hydrogymnastics [39–42]. “Vigor-
ous intensity” was defined as exercise causing a large increase in a person’s heart rate or
breathing (equivalent to>5.0 MET) such as jogging, cycling, soccer, tennis, basketball, and
keep-fit exercises [39–42]. Both moderate activities and vigorous activities were combined as
MVPA. Following the WHO PA recommendations for adults [16], the total volume of “walk-
ing” or MVPA (with “vigorous” multiplied by two to account for its greater intensity) each was
classified as 1) none (no PA reported), 2) <150 min/week, or 3)150 min/week.
Covariates
Sociodemographic variables were included as possible confounding factors of the association
between clinical conditions and QoL; these were selected based on findings from the literature
[14, 43–48]. Most of these variables were collected in the baseline of the EpiFloripa study or
third wave of the NWAHS (S1 Fig), and they included sex (male or female), age (continuous
variable, but also analyzed including a quadratic term due to nonlinear relationship with
QoL), marital status [married (includes living with a partner), single, or divorced/widowed],
educational level [up to secondary school, trade/certificate, or bachelor and higher (equivalent
to up to 11 years, 12–14 years, or 15+ years, respectively)], and family income. Family income
was collected as a continuous variable and classified into quartiles in the Brazilian study. In the
NWAHS, it was collected in eight categories, which were re-grouped into four [up to $20,000
(lowest), $20,001–$40,000 (low-middle), $40,001–$60,000 (middle-high), or more than
$60,000 (highest)] to obtain a more balanced distribution between categories.
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Data analysis
All analyses were performed separately for both studies, considering sampling weights (proba-
bility of selection in the baseline, probability of location in the follow-up, and re-weighted to
the population distribution) and the survey design in each study [32, 33].
For descriptive analyses, categorical variables were presented as percentages (%), while
numerical variables were described as means with their standard deviation (SD) or median
with interquartile range (p25-p75), depending on their distribution. Bivariate analyses between
sociodemographic variables, PA, and QoL (a continuous outcome) were performed with t-
tests or ANOVAs (the heterogeneity or trend depending on the nature of the independent
variables).
To test the association between clinical conditions (none, at risk of CVD, or with CVD)
and the physical and psychological domains of QoL, the outcomes of each study were stan-
dardised (Mean = 0, SD = 1) using the sample distribution to provide comparable results. Lin-
ear regressions were then used to evaluate the crude and adjusted associations between these
variables. Regression coefficients (β) and the respective 95% confidence intervals (95%CI)
obtained from these analyses were interpreted as the difference of QoL in SD between those at
risk or with CVD compared to the reference category (“none” of them). Sociodemographic
variables were included in the models as possible confounds [45, 46, 49], independent of their
level of statistical significance in the association with the outcomes. The variance inflation
factor (VIF) was investigated as an indicator of multicollinearity between the explanatory
variables.
The moderating role of PA was tested by the inclusion of multiplicative terms between
“walking” or MVPA time with the clinical health status. A p-value <0.10 for the multiplicative
term was considered as indicative of heterogeneity of the associations [50]. Predicted adjusted
means of QoL in each category of the PA level were then estimated and presented graphically
with their 95%CI, stratified by the respective clinical health status.
Coefficients of determination (R2) were used to assess the variance of QoL explained by the
models. All analyses were used the STATA software, version 13.0 (StataCorp, Texas, USA).
Results
Of the 1,720 adults included in the baseline of the EpiFloripa study, and the 4,060 participants
in the NWAHS, 71.0% and 70.7% were located in the last wave of each study (S1 Fig). Located
participants were comparable to the baseline sample regarding sex, age, marital status, educa-
tional level, and nutritional status (S1 Table). Thus, the Brazilian study included 1,222 adults
(38.8 ± 12.0 years, 48.2% males) and the Australian study included 1,661 individuals aged<65
years (43.7 ± 11.1 years, 49.7% males). Table 1 summarizes the sociodemographic and clinical
characteristics of the participants in each study.
The proportion of participants with at least 150 min/week of “walking” was higher in the
NWAHS, while MVPA of the same duration was lower in the same study. The prevalence of
hypertension and diabetes mellitus was similar in both studies, but the frequency of dyslipidae-
mia and obesity in the NWAHS was almost twice as high as in the EpiFloripa study. Con-
versely, the prevalence of CVD was higher in the Brazilian study. Nonetheless, the frequency
of individuals without any risk factor or CVD (“none”) was similar in both studies.
Fig 1 shows the prevalence of PA according to the clinical health status. In both studies, the
levels of “walking” were similar independent of whether the participants had a clinical history
of CVD or their risk factors (A). On the other hand, the percentage of individuals performing
any level of MVPA reduced progressively depending on whether they were at risk or affected
by a CVD (B). Nonetheless, this reduction was more evident in the EpiFloripa Study as the
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Table 1. Prevalence of sociodemographic and clinical variables among adults in the EpiFloripa study (Southern Brazil, 2012–2013) and North West Adelaide Health
Study (South Australia, 2008–2010).
Variables EpiFloripa (n = 1,222) NWAHS (n = 1,661)
% 95% CI % 95% CI
Sex: Males 48.2 45.1;51.4 49.7 46.3;53.1
Age
23 to 29 years 30.3 25.9;35.2 12.6 9.6;16.5
30 to 39 years 24.9 21.8;28.3 26.7 23.3;30.4
40 to 49 years 21.6 18.9;24.5 27.2 24.6;29.9
50 to 64 years 23.2 19.8;27.0 33.5 30.9;36.3
Marital status
Married 57.1 53.1;60.9 73.5 70.0;76.7
Single 34.6 30.6;38.9 16.9 13.8;20.5
Divorced/Widowed 8.3 6.6;10.4 9.6 8.2;11.3
Attained educational level
Up to secondary 55.6 48.1;62.9 40.8 37.6;44.2
Certificate/Diploma 14.0 11.2;17.2 35.1 31.8;38.5
Bachelor or higher 30.4 24.4;37.2 24.1 21.0;27.5
Family income#
Lowest 28.5 23.7;34.0 18.5 16.1;21.1
Low-middle 21.2 17.5;25.5 17.7 15.3;20.4
Middle-high 26.0 22.6;29.8 20.9 18.1;24.1
Highest 24.2 18.7;30.8 42.9 39.3;46.5
Walking
None 45.3 41.1;49.6 26.0 23.0;29.2
1–149 min/week 39.4 35.2;43.7 48.8 45.3;52.3
150 min/week 15.3 12.9;18.1 25.3 22.4;28.3
Moderate/vigorous PA
None 65.9 61.0;70.4 59.9 56.4;63.4
1–149 min/week 16.3 13.8;19.1 25.7 22.6;29.0
150 min/week 17.9 14.0;23.4 14.4 12.0;17.2
Risk factors (% Yes)
Hypertensiona 14.7 12.3;17.5 13.8 12.2;15.7
Dyslipidemiaa 4.5 3.2;6.2 9.5 8.2;11.0
Diabetes mellitusa 3.6 2.7;4.9 4.6 3.7;5.7
Obesityb 18.7 15.7;22.1 34.0 30.9;37.3
Abdominal obesityc 22.6 19.5;26.0 21.7 19.1;24.4
Clinical health status
None 63.4 58.9;67.6 59.1 55.8;62.4
At risk of CVD 29.9 26.4;33.8 36.1 33.0;39.4
With CVD 6.7 5.3;8.4 4.8 3.8;6.1
# Brazil: continuous variable presented in quartile. Australia: family income was collected in eight categories which were re-grouped to obtain a better balance between
categories (up to $20,000 (Lowest), $20,001–$40,000 (Low-middle), $40,001–$60,000 (Middle-high), or more than $60,000 (Highest)).
a—Based on medical diagnosis and/or medical treatment for that specific condition
b—Body mass index (BMI)30 kg/ m2, based on measured weight and height in Brazil and self-related in Australia
c—Upper quartile of waist circumference (Brazil: men >99.0 cm and women >89.6 cm; Australia: men >108.4 cm and women >99.2 cm)
Individuals with hypertension and/or dyslipidaemia and/or diabetes and/or obesity and/or abdominally obese, but without cardiovascular diseases
 Including myocardial infarction, angina, heart failure, atrial fibrillation/arrhythmia, and/or stroke (with or without cardiovascular diseases risk factor)
https://doi.org/10.1371/journal.pone.0198769.t001
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frequency of individuals with CVD practicing some level of MVPA (1–149 min/week = 9.9%
and150 min/week = 3.7%) was half the prevalence observed in the Australian study (8.3%
and 18.2%, respectively).
Regarding the QoL domains, even though a different instrument was used in each study,
the physical domain was slightly higher than the psychological domain, both in the Brazilian
(73.8 ± 6.2 and 71.6 ± 4.6, respectively) and in the Australian study (49.7 ± 8.2 and 47.6± 8.8,
respectively).
Table 2 shows the mean scores of QoL according to the sociodemographic and clinical vari-
ables. In general, the physical and psychological domains in both studies were higher in males,
Fig 1. Prevalence of PA according to the clinical health status among adults in the EpiFloripa study (Southern
Brazil) and North West Adelaide Health Study (NWAHS, South Australia). (A) “Walking”. (B) Moderate/vigorous
PA. At risk of CVD: Individuals with hypertension and/or dyslipidemia and/or diabetes and/or obesity and/or
abdominal obesity, but without cardiovascular diseases. With CVD: Including myocardial infarction, angina, heart
failure, atrial fibrillation/arrhythmia, and/or stroke (with or without risk factor).
https://doi.org/10.1371/journal.pone.0198769.g001
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younger individuals (there was no association with age for the psychological domain in Aus-
tralia), with a higher educational level, or higher family income. “Walking” of any duration
was associated with a better physical and psychological QoL in the Australian sample, but no
association with any domain was observed in the Brazilian study. However, in general, the
Table 2. Physical and psychological domains of quality of life according to sociodemographic and clinical characteristics in the EpiFloripa study (Southern Brazil,
2012–2013) and North West Adelaide Health Study (South Australia, 2008–2010).
Physical domain Psychological domain
Epifloripa NWAHS Epifloripa NWAHS
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
Sex p<0.001 p = 0.005 p = 0.001 p = 0.001
Male 76.6 75.3;77.9 50.5 49.8;51.2 73.0 71.9;74.1 48.6 47.8; 49.4
Female 71.3 69.6;72.9 49.0 48.2;49.8 70.2 68.9;71.5 46.6 45.7; 47.5
Age group p<0.001 p<0.001 p = 0.004 p = 0.700
20 to 29 years 77.3 75.6;79.0 51.9 50.0;53.8 73.3 71.6;74.9 48.2 45.6;50.8
30 to 39 years 74.0 71.9;76.0 50.3 49.1;51.6 71.5 69.3;73.7 47.1 45.6;48.6
40 to 49 years 73.4 71.5;75.4 50.3 49.5;51.2 71.9 70.3;73.4 48.0 47.0;49.1
50 to 64 years 69.5 66.8;72.2 47.9 47.2;48.6 69.1 67.5;70.7 47.4 46.8;48.1
Marital status p = 0.020 p = 0.010 p = 0.150 p<0.001
Married 73.1 71.6;74.6 50.0 49.4;50.6 71.1 70.0;72.3 48.2 47.6;48.8
Single 75.6 73.8;77.4 49.9 48.0;51.7 72.6 70.8;74.5 46.9 44.8;49.1
Divorced or widowed 71.5 67.8;75.3 47.2 45.5;48.9 70.0 67.0;73.0 44.0 42.0;46.0
Educational level p<0.001 p<0.001 p<0.001 p = 0.003
Up to secondary 71.8 70.2;73.5 48.5 47.7;49.3 69.0 67.7;70.3 46.6 45.7;47.6
Certificate or Diploma 75.6 73.4;77.8 49.5 48.5;50.4 74.3 71.6;77.0 47.8 46.6;48.9
Bachelor or higher 76.5 75.1;78.0 52.1 51.0;53.1 75.0 73.9;76.1 49.0 47.8;50.1
Family incomea p<0.001 p<0.001 p<0.001 p<0.001
Lowest 69.7 67.7;71.1 44.8 43.4;46.2 67.3 65.9;68.8 43.1 41.5;44.6
Low-middle 73.4 70.9;75.9 49.4 48.0;50.8 71.9 70.0;73.8 46.9 45.2;48.6
Middle-high 74.4 72.5;76.4 50.3 49.0;51.7 72.5 70.5;74.4 47.1 45.6;48.7
Highest 77.8 76.1;79.6 52.0 51.4;52.6 75.2 73.8;76.6 50.3 49.6;50.9
Walking p = 0.060 p<0.001 p = 0.848 p = 0.006
None 72.8 70.7;74.8 48.3 47.2;49.4 71.8 70.4;73.2 45.9 44.5;47.3
1–149 min/week 74.1 72.6;75.6 50.0 49.2;50.9 71.2 69.9;72.6 48.1 47.2;49.0
150 min/week 76.4 73.9;78.8 50.7 49.8;51.6 71.7 69.2;74.2 48.4 47.3;49.5
Moderate/vigorous PA p<0.001 p<0.001 p<0.001 p<0.001
None 72.5 71.0;74.0 48.3 47.5;49.0 70.6 69.5;71.6 46.7 45.9;47.5
1–149 min/week 76.5 74.2;78.8 51.2 50.1;52.2 72.5 70.1;75.0 47.9 46.5;49.3
150 min/week 76.4 74.1;78.6 53.3 52.3;54.2 74.3 72.8;75.9 50.9 49.6;52.2
Clinical health status p<0.001 p<0.001 p = 0.002 p<0.001
None 76.9 75.8;78.1 51.3 50.6;52.0 73.3 72.2;74.4 48.8 47.9;49.6
At risk of CVDb 69.3 67.4;71.2 47.7 46.8;48.5 68.5 66.9;70.0 46.0 45.0;47.0
With CVDc 65.2 59.6;70.8 45.4 43.1;47.7 68.9 65.7;72.1 45.2 42.5;47.8
P-value <0.05 according to a  t-test,  an ANOVA test for trend, or an ANOVA test for heterogeneity
a—Brazil: continuous variable presented in quartile. Australia: family income was collected in eight categories, which were re-grouped aiming to obtain a better balance
between categories (up to $20,000 (Lowest), $20,001–$40,000 (Low-middle), $40,001–$60,000 (Middle-high), or more than $60,000 (Highest)).
b–Individuals with hypertension and/or dyslipidaemia and/or diabetes and/or obesity and/or abdominally obese, but without cardiovascular diseases
c–Including myocardial infarction, angina, heart failure, atrial fibrillation/arrhythmia, and/or stroke (with or without cardiovascular diseases risk factor)
https://doi.org/10.1371/journal.pone.0198769.t002
Physical activity, CVD, and quality of life
PLOS ONE | https://doi.org/10.1371/journal.pone.0198769 June 7, 2018 9 / 17
highest physical and psychological QoL scores were observed among individuals in both stud-
ies practicing150 min/week of MVPA.
Table 3 shows the crude and adjusted associations between clinical health status and QoL
(standardised scores, as detailed in the Methods section). Results for the physical domain were
consistent in both studies in terms of magnitude and direction of the associations. After adjust-
ment for confounding variables, individuals at risk of CVD showed a physical score 0.3 SD
lower than the reference category (“none”), while among those with CVD the score was 0.5 SD
lower. The psychological domain in both studies was also lower among individuals at risk or
with CVD, either in crude or adjusted analyses. However, the magnitude of the association
with CVD was stronger in the Australian study (-0.43 SD; 95%CI -0.75;-0.11) compared to the
EpiFloripa study (-0.17 SD; 5%CI -0.40;-0.07), with no inverse-trend association between the
clinical health status and the psychological domain in the Brazilian study. No evidence of mul-
ticollinearity between the explanatory variables was identified, as the mean VIF did not exceed
1.25 in any model.
The moderating role of the PA levels on the association between the clinical health status
and QoL is shown in Fig 2. In general, “walking” time was directly associated with the physical
score of QoL in both studies, independent of clinical health status (A). However, the difference
between individuals practicing150 min/week and those who were inactive was higher
among participants at risk or with a CVD (differences between 0.3 and 0.6 SD, depending on
the study) compared to individuals without these conditions (differences between 0.1 and 0.2
SD). Furthermore, individuals at risk or with CVD practicing some level of “walking” tended
to show a mean closer to zero (i.e. equivalent to the study mean). The moderating role of
MVPA on physical QoL was less evident (B). In the Brazilian sample, MVPA was not associ-
ated with a better physical QoL among individuals who were healthy, at risk, or with CVD. In
the Australian study, MVPA showed a direct trend association with physical QoL among
healthy individuals; it was also beneficial for those at risk of CVD (similar effect for those
Table 3. Crude and adjusted analyses1 of the association between clinical health status and quality of life (physical and psychological domains) in the EpiFloripa
study (Southern Brazil, 2012–2013) and North West Adelaide Health Study (South Australia, 2008–2010).
Physical domain Psychological domain
Crude Adjusteda Crude Adjusteda
β (95% CI) β (95% CI) β (95% CI) β (95% CI)
EpiFloripa None Ref Ref Ref Ref
At risk of CVDb -0.46 (-0.58;-0.34) -0.37 (-0.50;-0.24) -0.34 (-0.48;-0.21) -0.27 (-0.41;-0.13)
With CVDc -0.71 (-1.04;-0.38) -0.54 (-0.87;-0.22) -0.31 (-0.54;-0.08) -0.17 (-0.40;-0.07)
p-value p<0.001 p<0.001 p<0.001 p<0.001
NWAHS None Ref Ref Ref Ref
At risk of CVDb -0.42 (-0.55;-0.30) -0.31 (-0.43;-0.19) -0.31 (-0.46;-0.17) -0.25 (-0.39;-0.11)
With CVDc -0.69 (-0.97;-0.41) -0.52 (-0.80;-0.24) -0.42 (-0.74;-0.09) -0.43 (-0.75;-0.11)
p-value p<0.001 p<0.001 p = 0.006 p<0.001
1 –Regression coefficients (β) and 95%CI are presented as standardised units, and should be interpreted as the difference of QoL in standard deviations (SD) between
those at risk or with CVD compared to the reference category (“none” of them). Physical domain—EpiFloripaWHOQoL SD = 6.2 and NWAHSSF-36 SD = 8.2.
Psychological domain—EpiFloripaWHOQoL SD = 4.6 and NWAHSSF-36 = 8.8.
a–Adjusted for variables sex, age, marital status, attained education level, and family income.
b–Individuals with hypertension and/or dyslipidemia and/or diabetes and/or obesity and/or abdominally obese, but without cardiovascular diseases
c–Including myocardial infarction, angina, heart failure, atrial fibrillation/arrhythmia, and/or stroke (with or without cardiovascular diseases risk factor)
 P-value for trend
https://doi.org/10.1371/journal.pone.0198769.t003
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practicing 1–149 or150 min/week). However, among individuals with CVD, it was associ-
ated with better physical QoL only when its duration was150 min/week.
Regarding the relationship with psychological QoL, in the Brazilian study (C) “walking”
time was not associated with this outcome among healthy participants or those at risk of CVD;
a lower score was observed among individuals with CVD practicing 1–149 min/week. In the
Australian study, individuals without any level of “walking” showed the lowest psychological
QoL score, especially if affected by CVD, and a direct trend association was observed between
“walking” time and psychological QoL among those at risk or with CVD. MVPA was associ-
ated with psychological QoL only in the Australian study (D), showing a direct trend associa-
tion between the two variables among healthy individuals. MVPA was also beneficial for those
at risk of CVD practicing150 min/week, but no association was found among individuals
with CVD.
Tests of heterogeneity for the moderating role of PA were<0.05 in all cases, except for the
association between MVPA and the psychological domain in the EpiFloripa study.
Compared to the models including just sociodemographic variables and clinical health sta-
tus, the inclusion of the PA variables in the regression models increased the variance of the
physical domain of QoL by approximately 20% (adjusted R2 changed from 14.3% to 17.2% in
the EpiFloripa study and from 16.9% to 19.9% in the NWAHS). For the psychological domain,
Fig 2. Predicted adjusted means of the physical and psychological domains of quality of life (standardised results)
according to the clinical health status and physical activity level in the EpiFloripa study (Southern Brazil, 2012–2013)
and North West Adelaide Health Study (South Australia, 2008–2010). Results are adjusted for sex, age, marital status,
attained education level, family income, and mutual adjustment between “walking” and MVPA. Individuals at risk include
those with hypertension, dyslipidaemia, diabetes, general obesity and/or abdominal obesity, but without CVD. CVD
include myocardial infarction, angina, heart failure, atrial fibrillation/arrhythmia, and/or stroke (with or without a risk
factor). Quality of life scores were standardised so that the variables have a mean = 0 and SD = 1 (original variables
Physical domain EpiFloripaWHOQoL = 73.8±6.2 and NWAHSSF-36 = 49.7±8.2; Psychological domain EpiFloripaWHOQoL =
71.6±4.6 and NWAHSSF-36 = 47.6±8.8). Vertical lines at the top of the columns represent the 95%CI.
https://doi.org/10.1371/journal.pone.0198769.g002
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the change in the adjusted R2 due to the inclusion of the PA variables was lower in the Brazil-
ian (R2 increased from 10.4% to 11.9%) than in the Australian study (13.8% and 16.3%,
respectively).
Discussion
This paper investigated the association between CVD and their risk factors with QoL in two
population-based cohort studies from Southern Brazil and South Australia. It also explored if
PA of different intensity and duration moderated that relationship. Four main findings can be
highlighted from our results. Firstly, individuals at risk or with CVD from both studies showed
a lower QoL than those without these conditions, and this relationship was stronger for the
physical domain. Secondly, although the association with the physical and psychological
domains of QoL were more evident for MVPA than “walking” time, individuals at risk or with
CVD were more likely to practice “walking” than other MVPA, especially in South Australia.
Thirdly, the direct trend association between “walking” and a higher physical QoL was stron-
ger among those at risk or with CVD than among those without these conditions in either
study. MVPA among individuals with CVD was associated with a better physical QoL only
when its duration was150 min/week, and this relationship was observed only in the Austra-
lian study. Finally, the moderating role of PA in the relationship between CVD and the psy-
chological domain was more evident in South Australia. Reduced “walking” time was
associated with a lower psychological score, and this adverse relationship was greater among
those with CVD, while the direct trend relationship between MVPA and psychological QoL
was evident only among ‘healthy’ individuals.
Our findings of lower physical scores compared to psychological scores for QoL among
individuals at risk or with CVD has been previously reported in the literature [5, 14, 45, 48].
The negative impact of CVD and CVD risk factors on physical QoL can be explained because
of the symptoms (i.e. dyspnea, chest pain) and physical functioning limitations (i.e. mobility
problems, difficulties to perform daily activities) related to these conditions [6, 7, 51–53].
Nonetheless, depression and anxiety are also common among these patients, and psychological
distress (i.e. fear of another heart attack, disruption of daily activities, frustration) and health
management issues (overwhelming treatment plans, poor coping after onset of disease) may
contribute to a lower psychological QoL [6, 7, 51, 52]. Moreover, although we identified in
both studies that the effect of having CVD was stronger than being affected only by their risk
factors, both conditions seem to have the same impact on QoL after the age 65 years [54].
Due to the stronger impact on physical health, PA has been recommended for the manage-
ment and prevention of CVD as it is beneficial for musculoskeletal fitness, reducing adiposity,
enhancing physiological parameters, improving symptoms, and reducing morbimortality [11–
13, 17, 18, 22, 53]. Furthermore, consistent with our results, PA is also beneficial for improving
psychological QoL and reducing adverse psychological stress parameters (depression, anxiety,
and hostility) [14, 21, 22, 24, 53].
Although different guidelines recommend exercising at least 150 minutes/week of MVPA
for individuals at risk or with CVD [12, 17], in both studies investigated in this study, individu-
als affected by these conditions were more likely to undertake “walking” than other MVPA.
Furthermore, according to our findings, “walking” was more important than other MVPA in
determining physical QoL among individuals at risk or with CVD, both in the Australian and
Brazilian samples. Although this could be a consequence of a higher frequency of individuals
at risk or with CVD “walking” than MVPA, diverse studies have reported that patients benefit
from PA programs even when they only include activities of lower intensity and/or duration
[13, 17, 22, 23, 43]. In fact, in our study, a dose-response relationship between MVPA and QoL
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(both physical or psychological domains) was observed only among healthy individuals in the
Australian study, while among those with CVD some benefit was observed only when prac-
ticed for150 min/week.
The less evident pattern for the associations between PA and QoL in the Brazilian study
could be partially explained by the problems experienced by low-and-middle income countries
in implementing existing PA national policies [i.e. insufficient workforce, lack of multisector
partnerships (i.e. health services, transport, education, sport/recreation, urban planning sec-
tors) and the absence of clarity about the most effective/feasible strategies] [55]. Furthermore,
patients with CVD and/or multiple CVD risk factors require medically supervised programs
for exercise training initiations and motivational strategies for long-term adherence [13].
Therefore, although Australia and Brazil provide universal access to a range of community and
emergency health services (including hospital care and prescriptions), Australia has one of the
most efficient articulated health system worldwide, largely focused on health promotion and
disease prevention, rather than on an acute care model [27–30]. These differences could
explain why “walking” was 65% more frequent in South Australia than in the Brazilian study,
and the fact that individuals at risk or with CVD practicing MVPA were twice more frequent
in the NWAHS than in the EpiFloripa study.
This study has some important strengths, including the investigation of two large popula-
tion-based samples of adults living in two cities from two countries with a similar profile of
NCD conditions but different socioeconomic contexts, the use of validated instruments to
assess QoL, and standardized methods for data collection and analysis. Nonetheless, some lim-
itations must be recognized. Firstly, the cross-sectional design of the analyses cannot be used
to infer causal associations (i.e. being active leading to a higher QoL, or vice versa, or even
mutual influence). However, longitudinal results from observational and intervention studies
have identified similar findings [12, 13, 21, 53]. Secondly, CVD and most CVD risk factors
were identified by self-reported diagnosis. Although we combined that information with the
use of medication for these conditions to improve accuracy, these kinds of data have interme-
diate levels of sensitivity (ranging from 33% to 85%) [56]. Even so, it is unlikely that this source
of bias could explain our results, as it would have reduced the magnitude of the associations.
Furthermore, although we did not investigate the severity of CVD conditions, some studies
have found that patients with mild or severe CVD have a similar impact on QoL [45, 57].
Thirdly, different generic questionnaires were used to measure QoL in each study (WHO-
QOL-Bref and SF-36) which have a different background, structure, domains, and scales [19,
37]. Despite this limitation, results for the physical domain were consistent in the two studies
regarding magnitude and direction of the associations. Finally, PA was assessed considering
different instruments in each study, and none of them allowed the investigation of the time/
frequency of other important sources of PA (at work, domestic chores, or other forms of low-
intensity PA). Nonetheless, these instruments have shown good reliability and validity com-
pared to gold standards in the assessment of leisure PA levels [39–41].
In conclusion, both in Southern Brazil and South Australia, adults at risk or with CVD
reported lower QoL compared to healthy individuals, and this deleterious relationship was
stronger with the physical compared to the psychological domain. “Walking” time was a more
important moderator than other MVPA to mitigate the adverse effects of CVD and their risk
factors on QoL, and these results were more consistent in South Australia than in Southern
Brazil. Our findings highlight the need to reconsider the recommendations about the forms
and intensity of PA indicated for the management and prevention of CVD, as “walking” is also
more prevalent in the community and requires less professional advice to be given compared
to MVPA among individuals at risk or with CVD. These factors should be considered in the
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design and implementation of public health interventions aiming to promote PA, improve
QoL and reduce the impact of CVD.
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